Literature DB >> 16323036

Prevalence and correlates of HIV risk behaviors among drug users in China.

Xiushi Yang1, Carl Latkin, David Celentano, Huasong Luo.   

Abstract

This study examined the prevalence and correlates of HIV risk behaviors among 1,153 current drug users in China. Chi-squared tests of differences were used to test if drug users differed from non-users; logistic regression was used to identify behavior-specific risk factors. Results indicate that 60% of drug users injected drugs and more than one third shared needles. Compared to non-users, drug users had higher rates of risky sexual behavior and HIV/STDs. Among drug users, ethnic minorities and migrants were most vulnerable to unprotected casual sex and needle sharing. Drug users who experienced social isolation were associated with lower odds of risk behaviors; those who had experiences of anti-social behaviors and commercial sex, poor HIV knowledge, and perceived greater vulnerability were more prone to unprotected casual sex and needle sharing. Additional correlates of unprotected casual sex included being single, depression, and taking drugs/alcohol during sex. Additional risk factors of needle sharing included education and initiated drug use at younger ages. It is imperative that HIV interventions in China target drug users and address behavior-specific risk factors.

Entities:  

Mesh:

Year:  2006        PMID: 16323036     DOI: 10.1007/s10461-005-9028-8

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  15 in total

1.  Risks for HIV infection among male street laborers in urban Vietnam.

Authors:  Huy Van Nguyen; Michael P Dunne; Joseph Debattista
Journal:  J Community Health       Date:  2013-08

2.  A qualitative study on commercial sex behaviors among male clients in Sichuan Province, China.

Authors:  Cui Yang; Carl A Latkin; Peng Liu; Kenrad E Nelson; Cunlin Wang; Rongsheng Luan
Journal:  AIDS Care       Date:  2010-02

3.  Peer norms and consistent condom use with female sex workers among male clients in Sichuan province, China.

Authors:  Cui Yang; Carl Latkin; Rongsheng Luan; Kenrad Nelson
Journal:  Soc Sci Med       Date:  2010-05-25       Impact factor: 4.634

4.  Predictors of accessing antiretroviral therapy among HIV-positive drug users in China's National Methadone Maintenance Treatment Programme.

Authors:  Yan Zhao; Cynthia X Shi; Jennifer M McGoogan; Keming Rou; Fujie Zhang; Zunyou Wu
Journal:  Addiction       Date:  2015-01       Impact factor: 6.526

5.  HIV, syphilis, hepatitis C and risk behaviours among commercial sex male clients in Sichuan province, China.

Authors:  Cui Yang; Carl Latkin; Rongsheng Luan; Cunling Wang; Kenrad Nelson
Journal:  Sex Transm Infect       Date:  2010-09-08       Impact factor: 3.519

Review 6.  Alcohol use and sexual risk behaviors and outcomes in China: a literature review.

Authors:  Qing Li; Xiaoming Li; Bonita Stanton
Journal:  AIDS Behav       Date:  2010-12

7.  Social injecting and other correlates of high-risk sexual activity among injecting drug users in northern Vietnam.

Authors:  Christina M Schumacher; Vivian F Go; Le Van Nam; Carl A Latkin; Anna Bergenstrom; David D Celentano; Vu Minh Quan
Journal:  Int J Drug Policy       Date:  2008-11-17

8.  Alcohol use and subsequent sex among HIV-infected patients in an ethnic minority area of Yunnan Province, China.

Authors:  Xiaofeng Luo; Song Duan; Qixiang Duan; Yongcheng Pu; Yuecheng Yang; Yingying Ding; Meiyang Gao; Na He
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

9.  Modeling predictors of risky drug use behavior among male street laborers in urban Vietnam.

Authors:  Van Huy Nguyen; Michael P Dunne; Joseph Debattista
Journal:  BMC Public Health       Date:  2013-05-07       Impact factor: 3.295

10.  Infection status and risk factors of HIV, HBV, HCV, and syphilis among drug users in Guangdong, China--a cross-sectional study.

Authors:  Jie Wu; Jinying Huang; Duorong Xu; Ciyong Lu; Xueqing Deng; Xiaolan Zhou
Journal:  BMC Public Health       Date:  2010-11-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.